FindTrial
Sign In

Expression of NLRX1, TRAF6 in human colorectal carcinoma and their relationship with clinicopathological characteristics

Expression of NLRX1, TRAF6 in human colorectal carcinoma and their relationship with clinicopathological characteristics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020959
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-01-28
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenterology tumor

Interventions

Cases versus control:Nil

Sponsors

THE THIRD PEOPLE'S HOSPITAL OF DALIAN
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The specimens of colorectal cancer tissues were taken from January 2019 to June 2020 from the resected tissues of colorectal cancer and normal tissues adjacent to the cancer in the general surgery department of the Third People's Hospital of Dalian City.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
NLRX1;TRAF6;—

Countries

China

Contacts

Public ContactFAN ZHE

THE THIRD PEOPLE'S HOSPITAL OF DALIAN

fanzhe1982@hotmail.com+86 13704289183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026